Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-034877

Chief Business Development Off sold 6,770 shares at $40.00 ($270,800)

  • Chief Business Development Off acquired 6,770 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BENZENO SHARON Chief Business Development Off 2020-06-03 Option exercise +2,604 $6.55 $17,056 2,604 D
BENZENO SHARON Chief Business Development Off 2020-06-03 Option exercise +2,604 $6.55 $17,056 5,208 D
BENZENO SHARON Chief Business Development Off 2020-06-03 Option exercise +1,562 $7.27 $11,356 6,770 D
BENZENO SHARON Chief Business Development Off 2020-06-03 Sale −6,770 $40.00 $270,800 0 D
Derivatives
BENZENO SHARON Chief Business Development Off 2020-06-03 Option exercise · Stock Option (Right to Buy) −2,604 43,271 D
BENZENO SHARON Chief Business Development Off 2020-06-03 Option exercise · Stock Option (Right to Buy) −2,604 72,917 D
BENZENO SHARON Chief Business Development Off 2020-06-03 Option exercise · Common Stock (Right to Buy) −1,562 48,438 D
Open-market sales · 6,770 sh · avg $40.00 · $270,800
Loading xslF345X03/doc4.xml…